Nursing Alchemy: Transforming R-CHOP Information Into Essentials

A combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is a first-line combination chemotherapy regimen for diffuse large B-cell lymphoma that has many nursing implications. Understanding the mechanisms of these chemotherapy agents helps in understanding the administration and management of clinical care.